Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study.
Am J Hypertens. 2019 Jan 1;32(1):18-25. doi: 10.1093/ajh/hpy142.
Am J Hypertens. 2019.
PMID: 30256890
Free PMC article.